<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1856953457853813&amp;ev=PageView&amp;noscript=1">

VLCM Foundation

VLCM Foundation Offers Donors the Chance to Tour HCI

Posted by Elise Vandersteen Bailey on Dec 14, 2018 11:40:14 AM


Read More

Got questions about cancer?

Posted by Elise Vandersteen Bailey on Nov 2, 2018 8:25:00 AM

Okay, this week's post is going to be a bit different than usual.

My name is Elise Bailey, I work for VLCM Foundation. If you've read an email, blog article, or social media post from us in the last few years, I wrote it. If you've ever contacted VLCM Foundation, you probably talked to me.

If there's one thing I've learned working here over the last few years, it's that people in this community we've built around funding research at Huntsman Cancer Institute really care about the science done there. It's not just about a great day of golf with coworkers or friends. We've had the pleasure of bringing a researcher from HCI to you at the golf tournament for the least two years, and hearing how much people enjoyed that. We've also been lucky enough to take some of our donors to HCI and show them how it all happens. I have been floored (although I probably shouldn't have been) at the amazing questions that have been asked of scientists during those tours. And we know that people in general have questions about cancer. It's complicated and confusing. We have an entire series of articles answering the questions people frequently Google about cancer.

In light of that, I'd like to give you the opportunity to ask any question you'd like about cancer, cancer research, and Huntsman Cancer Institute. I'll chase the answers down for you. 

Read More

Topics: Science

HCI - Stanford Team Identifies "Promising Target" for Childhood Brain Cancer

Posted by Elise Vandersteen Bailey on Oct 26, 2018 9:20:00 AM



Medulloblastoma is one of the most common brain cancers in children and infants, and Group 3 medulloblastoma is the most aggressive subtype of that cancer. It accounts for fully 28% of all medulloblastomas and is associated with both fast spread and poor survival. When group 3 medulloblastoma metastasizes, it usually spreads to the spinal cord—which is enclosed inside the vertebrae (those bones in your back). Once group 3 medulloblastoma spreads, it becomes much more difficult to treat--as with many cancers. Scientists have had little success understanding this process in medulloblastoma, until very recently at Huntsman Cancer Institute.

Read More

Topics: Science

HCI Lung Cancer Research Reveals New Treatment Targets

Posted by Elise Vandersteen Bailey on Oct 19, 2018 8:25:00 AM

Lung cancer, as we've talked about before, is very common and very deadly. It's frequently caught late and isn't very treatable. Many researchers are dedicated to understanding and treating the disease. One such research lab at Huntsman Cancer Institute has recently made a breakthrough in how we look at lung cancer.

Read More

Topics: Science

More Evidence that Aspirin May Have Anti-Cancer Effects

Posted by Elise Vandersteen Bailey on Oct 12, 2018 8:45:00 AM

It has long been suggested that regular use of aspirin might lower the risk of developing cancer. For one cancer—colorectal—the idea is clearly supported by research evidence. For others like melanoma, ovarian cancer, pancreatic cancer, and a kind of liver cancer called hepatocellular carcinoma, the evidence is mixed. A recent paper with Huntsman Cancer Institute ties adds to the evidence that regular aspirin use decreases the risk of ovarian cancer.

Read More

Topics: Science

Hope on the Horizon for Several Potential Melanoma Preventions

Posted by Elise Vandersteen Bailey on Oct 5, 2018 8:15:00 AM



Experts on melanoma--a type of skin cancer--from the Melanoma Prevention Working Group recently authored a paper summarizing current research into both drugs and natural products that prevent melanoma. They name several of these as candidates to enter phase 3 clinical trials in the next 5 years. Two of these experts are researchers at Huntsman Cancer Institute: Tawnya L. Bowles and Douglas Grossman.

Read More

Topics: Science

Keep Up With VLCM

Get IT news and blog updates delivered to your inbox.

Subscribe to Email Updates

Recent Posts